Key result
Thoracoscopic LAAO in AF is associated with ~99% midterm freedom from stroke or TIA.
Why the study?
Thoracoscopic left atrial appendage occlusion, with or without ablation, is an alternative to endocardial devices or anticoagulation for stroke prevention in AF, but multicenter data are limited.
Does thoracoscopic LAAO with or without ablation prevent cerebrovascular events in patients with nonvalvular AF?
Observational (n=567)
Yes
Does thoracoscopic LAAO with or without ablation prevent cerebrovascular events in patients with nonvalvular AF?
Thoracoscopic LAAO, with or without ablation, is a safe and effective stroke prevention strategy for patients with nonvalvular AF, allowing for high rates of anticoagulant withdrawal and very low midterm thromboembolic events.
Supports thoracoscopic LAAO for AF stroke prevention; leaves open role of concomitant ablation pending randomized trials.
Background: Atrial fibrillation (AF) is a major risk factor for ischemic stroke, with >90% of thrombi in nonvalvular AF originating in the left atrial appendage (LAA). Thoracoscopic LAA occlusion (LAAO), with or without ablation, is a minimally invasive alternative to endocardial devices or anticoagulation, but multicenter data are limited. Methods and Results: VASc scores were 2 and 4, respectively. Success was 99.8% with no intraoperative deaths; residual stumps >10 mm were found in 1.5%. At discharge, sinus rhythm was present in 45%. Anticoagulants were stopped in 15% immediately and 63% within 1 month. During 875.8 patient years of follow-up (median 13 months), freedom from stroke or transient ischemic attack was 99.5% (0.34/100 patient years), with no thromboembolic deaths. Conclusions: Thoracoscopic LAAO, with or without ablation, is safe and effective for stroke prevention in AF, with high success, reliable closure, and very low midterm events.
No takes yet. Share an insight, caveat, or question.
Nakayama et al. (2026) conducted an observational in Atrial fibrillation (n=567). Thoracoscopic Left Atrial Appendage Occlusion was evaluated on Freedom from stroke or transient ischemic attack. Thoracoscopic LAAO is safe and effective for stroke prevention in AF, with high success rates and low midterm events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: